Hemorrhagic stroke associated with Prasugrel treatment: a review of the literature

María Eugenia Piesciorovsky and Claudia Sabattini Analía

Rehabilitation and Sports Medicine, 2025, vol. 5, 37

Abstract: Introduction: patients receiving treatment with Prasugrel for the prevention of acute coronary artery disease may suffer a hemorrhagic stroke as a complication, this being one of the most serious complications and with the highest mortality associated with the use of antiplatelet agents. Objective: to analyze the relationship between antiplatelet therapy with Prasugrel and the occurrence of hemorrhagic stroke. Methods: search of information in the Scopus, Web of Science and SciELO databases on hemorrhagic encephalic vascular accidents during the use of Prasugrel. Results: a total of 50 articles were found that met the inclusion and exclusion criteria, 3 of which were used for this study. Conclusion: risk factors such as arterial hypertension, diabetes, advanced age predisposes patients to hemorrhagic stroke during treatment with Prasugrel

Date: 2025
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:rehabi:v:5:y:2025:i::p:37:id:37

DOI: 10.56294/ri202537

Access Statistics for this article

More articles in Rehabilitation and Sports Medicine from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().